Trial

NCT05401058

Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery
UnknownTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
RenJi Hospital
Collaborators
Condition
Digestive System Disease
Intervention
Droperidol Injection
Why stopped
The trial was terminated on the independent DSMB's recommendation after an interim analysis showed no evidence of benefit and a numerically higher incidence of postoperative delirium in the droperidol group, raising a potential safety concern.
Provenance
Dataset: 2026-08-14 • Source: ClinicalTrials.gov API v2 • Last update: 2026-08-12